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Abstract
Background: The role that the peritumoral stroma plays in the growth of tumours is currently poorly understood.
In this manuscript the morphometric characteristics of basal cell carcinoma subtypes and their associated
peritumoral stromas are presented.
Methods: Ninety eight digitized basal cell carcinoma histology slides were categorized as infiltrative, nodular, or
superficial subtypes, and were analysed using a combination of manual and computer-assisted approaches. The
morphometric characteristics of the tumour nests and their associated peritumoral stroma were quantified, and the
presence of a marked immune reaction or elastosis was noted.
Results: The tumour to stroma ratio was different among each tumour subtype. Elastosis was identified in a
greater proportion of the infiltrative tumours.
Conclusions: Quantitative differences exist between the peritumoral stroma of basal cell carcinoma subtypes.
Future work exploring the relation between these morphometric differences and biochemical variations in
peritumoral stroma may further our understanding of the biology of carcinoma development.
Trial Registration: Not applicable.
Background
Carcinomas (cancers derived from epithelial cells) are
accompanied by a specialized peritumoral stroma which
plays an important but poorly understood role in the
growth and metastasis of the tumour [1-4]. The peritu-
moral stroma is composed largely of activated fibro-
blasts, inflammatory cells and vasculature and engages
in a complex crosstalk with the developing tumour. This
interplay appears to be mediated largely by soluble para-
crine factors [1-17].
Modifications to the peritumoral stroma include
alterations in the secretion of extracellular matrix pro-
teins and growth factors by fibroblasts. Particularly
important are the stromally expressed matrix metallo-
proteinases (MMPs), which may have wide-ranging
effects on tumor growth, angiogenesis and metastasis
[17]. A number of other soluble fibroblast-derived fac-
tors have been shown to induce carcinoma initiation
and progression with Wnt-1, HGF and TGF-b playing
particularly prominent roles [18]. Gene expression pro-
filing of both stroma and tumor in an inducible human
neoplasia model showed that during tumour growth epi-
dermal tissue first showed increased expression of genes
mediating cellular biosynthesis followed by increased
expression of genes promoting proliferation and lastly
increased expression of genes involved in extracellular
matrix remodelling and increased cell motility. In con-
trast, gene expression by stromal fibroblasts shows a dif-
ferent pattern with early increased expression of genes
involved in angiogenesis [13].
In addition to the paracrine factors secreted by fibro-
blasts, inflammatory cells in the peritumoral stroma also
secrete growth factors, as well as reactive oxygen species
which may further effect cancer growth [19]. Likewise,
complex interactions involving activated fibroblasts and
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[10].
As a model for the interaction between epithelial tumor
cells and stroma, basal cell carcinomas (BCC) offer a
number of unique opportunities to study these processes.
In addition to being the most common malignant tumor,
at least in Caucasians [20], BCC are accompanied by a
well-defined peritumoral stroma. The contribution of
this peri-tumoral stroma to the growth of BCCs is parti-
cularly interesting as several studies have found that the
growth of BCCs is stroma-dependent and limited by host
immune response. For example, human to mouse mice
BCC transplants are only successful in T, B, and NK cell
deficient mice [21-23]. Moreover, the variety of morpho-
logical patterns of this tumor provides an opportunity to
study associations between stromal variation and tumor
architecture.
Previous work on BCC peritumoral stroma has defined
some qualitative features of this tissue. Work by Hum-
phreys et al. has shown an increased number of mast
cells and dermal dendrocytes expressing CD34 and GP1b
adjacent to BCC tumor nests, although no differences
were noted among tumor subtypes [24]. In contrast,
among the three most common histological patterns of
BCC growth (nodular, infiltrative and superficial) striking
differences in the expression of CD44 glycoprotein
expression molecules have been observed, with infiltra-
tive tumors showing the greatest expression of CD44 iso-
forms as revealed by immunohistochemical staining [25].
Dingemans et al. suggest that this finding indicates that
CD44 may play an important role in BCC biology and
specifically in determining the histological growth pattern
and degree of tumor invasiveness. This same study
reported that a-smooth muscle actin positivity (as a mar-
ker of myofibroblastic differentiation) tended to be great-
est in infiltrative tumor areas [22]. Thus there appear to
be qualitative differences in BCC peritumoral stroma
which are associated with variations in histological
growth pattern.
In addition to biochemical factors, some morphometric
characteristics of BCCs have been explored. Studies
performed by Dixon et al. [26] and Jacobs et al. [24] have
investigated the relationship between tumour nest mor-
phology and tumour aggressiveness. Significant relation-
ships were found between non-circular nests, smaller
degrees of peripheral palisading, and tumour aggressive-
ness. Dixon et al. [26] and Jacobs et al. [27] also found that
fibrous stroma was associated with less aggressive
tumours, and that hyalinization was present in the stromas
of more aggressive tumours. A couple of studies have also
explored the relationship between nuclear cell morphome-
try and tumour aggressiveness [28,29]. De Rosa et al. [28]
claimed that higher nuclear areas and perimeters were
associated with increased aggressiveness; however Appel
et al. failed to replicate this finding [29]. Of particular
note, de Rosa et al. also observed an increased incidence
of hyalinization in the stroma of the aggressive tumours
[28]. Considering that previous studies focused primarily
on the tumour nests, further investigation into the rela-
tionships between the peritumoral stroma and tumour
morphometry may be of interest.
T h ep u r p o s eo ft h i ss t u d yi st oe m p l o ya d v a n c e d
image analysis techniques to look for patterns in the
quantitative relationship between different BCC histol-
ogy patterns and the BCC peritumoral stroma.
Methods
Case selection/image acquisition
Cases were selected from the routine clinical caseload of
the senior author. Images of 98 hematoxylin and eosin
stained slides were digitized using a commercial Aperio
CS-O slide scanner at 80 × magnification, and sections
containing BCC were stored as JPEG images (1072 × 902
pixels). To avoid possible confounding effects of biopsy
site changes and wound healing on the morphological
assessment of tumour subtype [30,31], we excluded any
cases that were previously biopsied. We did not include
any cases with prior biopsies. Do to a lack of recognized
classification schemes for bas a lc e l lc a r c i n o m as t r o m a ,
we did not attempt to sub-classify stroma types.
The study protocol was reviewed by the Calgary
Laboratory Services Research Committee and deemed to
represent a method development project not requiring
further ethics approval (CLS Study Code RS-11-504).
Image analysis
Printed copies of each of the 98 BCC images were initially
evaluated manually. In each BCC image five neoplastic
regions of interest (ROI) were identified, and their stromal
diameters and tumour radii were delineated. ROIs were
selected based on the following criteria: (i) the area must
be free of technical artefacts such as variations in staining
and cutting of slides and must not include borders of the
tissue sample or image, and (ii) ROIs must include only
one subtype of tumor (i.e. not transitional or combined
tumours). When possible each ROI was selected from a
separate tumour nest. Multiple ROIs were identified in the
same tumour nest only when the total number of tumour
nests was fewer than five. The tumour radii and stroma
diameters were measured directly from the printed image
for each ROI. A limitation to this approach arose where
tumour nests were close together and the intervening
space was entirely composed of peri-tumoural stroma. In
this instance stroma attributable to each nest was arbitra-
rily defined as the stroma between them divided by two.
Finally, the presence of inflammation or elastosis was
noted, and the tumour subtype for each slide was categor-
ized as nodular, superficial, or infiltrative.
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digital imaging and analysis software ImageJ (version
1.44p) was used to quantify the morphology of the
tumour nests in each slide. By measuring the circularity
of the tumour nest associated with each of the ROIs,
the tumour nest roundness was quantified. The circular-
ity measurement in ImageJ is calculated as follows:
circularity =
4 · π · area
perimeter2
A circularity measurement of 1 indicates a perfect cir-
cle, while more elongated shapes result in lower values
[32]. In order to avoid artificially low circularity mea-
surements, tumour nests cut off extensively by the
image edge were excluded from this analysis.
Visual tumour classification
Images were classified into tumor subtypes according to
the definitions provided by Crowson [33]. The 98 images
were composed of 23 superficial BCCs, 60 nodular BCCs
and 15 infiltrative BCCs. The presence of both solar elas-
tosis and an accompanying chronic immune response
were subjectively scored with absent and mild counted as
negative and moderate and marked counted as present.
Statistical analysis
Data analyses were performed using IBM SPSS Statistics
v19. Box plots of the morphometric statistics and bar plots
of the categorical statistics were created using R v2.13.0.
Non-parametric tests were employed, as initial calculations
indicated non-normal distributions. An analysis of var-
iance was performed using the Kruskal-Wallis test, and
Mann-Whitney tests were employed when significant dif-
ferences between the groups were found. Categorical vari-
ables were analysed using the Chi-squared test. Interaction
effects between continuous and categorical variables were
tested using binary logistic regression.
Results
Examples of the different basal cell carcinoma subtypes
included in this study are illustrated in Figure 1. Statisti-
cally significant differences were found among tumor
subtypes with regard to median tumour radii (p =
0.005), stroma diameters (p = 0.008), and tumour to
stroma ratio (p = 0.000006). Post hoc pairwise compari-
sons showed different median tumour radii (p = 0.0009)
and stroma diameters (p = 0.003) between the infiltra-
tive and nodular subtypes. For each of the tumour sub-
types different tumour-to-stroma ratios were obtained
(infiltrative-nodular p = 0.00006, infiltrative-superficial
p = 0.006, nodular-superficial p = 0.005). There was
insufficient statistical evidence to conclude that circular-
ity varied by tumour subtype (p-value = 0.3). The
morphometric comparisons are summarized in Figure 1
and Table 1.
The presence of elastosis was correlated with the
tumour subtype (p = 0.033), as eight of the fifteen (53%)
infiltrative, twelve of the sixty (20%) nodular, and six of
the twenty-three (26%) superficial tumours contained
Figure 1 Examples of basal cell carcinoma subtypes included
in this study: (a) nodular, (b) superficial, (c) infiltrative.
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Variable Infiltrative (n = 15) Nodular (n = 60) Superficial (n = 23) All (n = 98) P1
(Infiltrative-Nodular)
P2
(Infiltrative-Superficial)
P3
(Nodular-Superficial)
Tumour radius
(microns)–median
(IQR)
52.92 (39.56,
59.22)
71.83 (55.45,
94.95)
56.62
(50.32,
97.92)
64.29
(53.16,
91.24)
0.0009 0.06 0.3
Stroma width
(microns)–median
(IQR)
34.12 (28.44,
40.56)
25.72 (20.28,
30.17)
30.17
(23.24,
44.02)
27.44
(21.52,
34.86)
0.003 0.5 0.08
Tumour to stroma
ratio–median (IQR)
1.492 (1.308,
1.726)
2.842 (2.023,
4.005)
1.894
(1.627,
2.691)
2.170
(1.692,
3.330)
1.129e-06 0.006 0.005
Circularity–median
(IQR)
0.3808
(0.3158,
0.4112)
0.4475
(0.3328,
0.5672)
0.4580
(0.2616,
0.5813)
0.4266
(0.3155,
0.5652)
0.1 0.3 0.97
P1 = p-value obtained for the difference between the median variable values between the infiltrative and nodular subtypes. A two tailed Mann-Whitney test was used with a 95% confidence interval
P2 = p-value obtained for the difference between the median variable values between the infiltrative and superficial subtypes. A two tailed Mann-Whitney test was used with a 95% confidence interval
P3 = p-value obtained for the difference between the median variable values between the nodular and superficial subtypes. A two tailed Mann-Whitney test was used with a 95% confidence interval
IQR = interquartile range
L
e
s
a
c
k
a
n
d
N
a
u
g
l
e
r
B
M
C
D
e
r
m
a
t
o
l
o
g
y
2
0
1
2
,
1
2
:
1
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
5
9
4
5
/
1
2
/
1
P
a
g
e
4
o
f
7elastosis. The presence of an immune reaction was not
found to be significant (p = 0.1). The categorical statis-
tics are summarized in Table 2. Possible interaction
effects between dermal elastosis (significant in univariate
analysis) and the continuous variables were explored
using binary logistic regression. No statistically signifi-
cant associations were found using this approach (analy-
sis not shown).
Discussion
This study quantified the morphometric relationships
between basal cell carcinoma subtypes and their
peritumoral stroma. Manual and computer-assisted
methods were employed to quantify size and shape sta-
tistics for infiltrative, nodular, and superficial BCC sub-
types. The presence of inflammation and elastosis was
also noted for each subtype.
Significant differences were found between the median
tumour radii and stroma diameters of the infiltrative
and nodular subtypes. The infiltrative subtype was asso-
ciated with thicker stroma, but smaller tumour radii,
with a correspondingly smaller tumour-to- stroma ratio.
Therefore the biochemical differences previously
described for infiltrative versus other BCC subtypes may
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Figure 2 Box and whisker plots for the mean tumour radii (A), stroma diameters (B), tumour to stroma ratios (C), and circularities by
tumour subtype (D).
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tumoral stroma.
Another noteworthy finding was that elastosis was
present in a significantly higher proportion of the infil-
trative subtype images. One possible explanation for this
finding is that the presence of extensive sun damage
contributes to the phenotype of BCC, predisposing to an
infiltrative growth pattern. Possible mechanisms for such
a relationship are speculative but may include differ-
ences in diffusion characteristics or paracrine factor
expression in sun damaged skin. Similar arguments
could be made for the presence of a chronic immune
infiltrate associated with infiltrative BCC: lymphocytes
could be recruited in response to some characteristic of
the tumor or they may themselves secrete factors that
influence the BCC phenotype.
Unexpectedly, the circularity of the tumour nest was
not found to influence the tumour subtype. This may
have resulted from the presence of nodular tumour nests
within some of the infiltrating subtype slides, resulting in
higher mean and more variable circularity measurements.
Alternatively, variance of the circularity measurements
among tumor nests on the same slide may provide a
means of distinguishing the tumour subtypes based on
their shape. Moreover, the use of different shape metrics
may provide a superior means of distinguishing tumour
subtypes based on their morphology. These questions
could be explored in future studies.
This study was unique in several ways. First of all, a
greater emphasis was placed on the relationship of the
tumour morphometry and its stroma. Previous studies
have focused largely on the tumour itself, therefore
ignoring an important factor in tumour growth. Another
benefit was that the shape statistics were quantified using
an open-source digital imaging and analysis program.
This facilitates replication, as ImageJ is freely available
and is capable of providing circularity measurements
with the default package. A further benefit of using soft-
ware to quantify the tumour nest shape is that it elimi-
nates the subjectivity resulting from categorizing the
tumour shape qualitatively. Further research could
improve upon this study in a couple of ways. One
limitation was that rarer BCC subtypes were not
included. Also, as mentioned earlier, inherent in an
observational study is the fact that it was not possible to
determine whether stromal differences influenced the
tumour architecture or if they resulted from the architec-
ture itself. Another limitation of this study concerns the
applicability of our findings to other malignancies. Basal
cell carcinomas differ from many other malignancies in
that they exhibit limited metastatic potential and often
lack features common to other malignancies such as
aneuploidy [34].
Previous studies that have quantified the morphometry
of BCC have focused on the relationship of the tumour’s
characteristics and its aggressiveness. Furthermore, these
studies have focused mainly on the tumour, rather than
its relationship to its stroma. As a result, it is not possible
to directly compare the findings presented here with
those of the previous BCC morphometry studies. That
aside, previous authors have found that aggressive
tumours have different morphometric characteristics
than non-aggressive ones. This may be related to the dif-
ferent morphology found between the different subtypes
in this study. The results obtained are also consistent
with the presence of biochemical differences that were
previously reported. As discussed, Humphreys et al. [24]
found that the expression of CD44 glycoprotein differed
amongst the infiltrative, nodular, and superficial sub-
types, with infiltrative tumours showing the highest
expression. The expression of CD44 may have contribu-
ted to the greater stroma diameters and lower tumour
radii measured for the infiltrative subtypes in our study.
Humphreys et al. [24] also reported greater a-smooth
muscle actin positivity in the infiltrative tumours, and
Papanikolaou [35] demonstrated integrin-linked kinase
(ILK) overexpression in infiltrative tumours, which may
also have contributed to the morphological differences.
Conclusions
I nt h i ss t u d yw ed e m o n s t r a t e dt h a tt h e r ea r eq u a n t i t a -
tive differences in the peritumoral stroma among BCC
subtypes. Future work should focus on integrating these
morphometric differences with the previously described
Table 2 Presence of immune reactions or elastosis in basal cell carcinomas.
Characteristic Infiltrative
1
(n = 15)
Nodular
1
(n = 60)
Superificial
1
(n = 23)
P1
(Infiltrative-Nodular)
P2
(Infiltrative-Superficial)
P3
(Nodular-Superficial)
Immune
Reaction
4 (0.27) 18 (0.30) 12 (0.52) 1.0 0.32 0.14
Elastosis 8 (0.53) 12 (0.20) 6 (0.26) 0.0057 0.17 0.37
Chi-squared tests were used except where an individual cell had a value less than five in which case a Fisher’s exact test was used
1 Data are presented as totals and proportions
P1 = p-value obtained for the difference between the median variable values between the infiltrative and nodular subtypes
P2 = p-value obtained for the difference between the median variable values between the infiltrative and superficial subtypes
P3 = p-value obtained for the difference between the median variable values between the nodular and superficial subtypes
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among BCC subtypes.
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